Itraconazole Pellets bulk supplier for pharma manufacturers

Itraconazole Pellets Suppliers & Bulk Manufacturers

Available Forms: Pellets

Available Strengths: 100 mg or 200 mg

Reference Brands: Sporanox

Category: Active Pharmaceutical Ingredient

Itraconazole Pellets is available in Pellets and strengths such as 100 mg or 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Itraconazole Pellets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Itraconazole Pellets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Itraconazole pellets API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves validation, safety testing, and clinical validation. In the EU, CE marking certifies conformity under MDR regulations. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality itraconazole pellet APIs vital for treating systemic fungal infections worldwide, supporting effective disease management and patient outcomes.

Frequently Asked Questions

Yes, Itraconazole Pellets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Itraconazole Pellets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Zinc Sulfate Powder

Strength:
Typically supplied as high-purity powder or crystals

Form: Powder/Granules or lumps

Reference Brands: Generic zinc sulfate

View Details
Clotrimazole Granules Or Pastes

Strength:
High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Clotrimazole Granules Or Pastes

Strength:
High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Mupirocin Granules

Strength:
Pharmaceutical-grade powders for formulation into topical creams, ointments, or injectable products

Form: Granules/powder

Reference Brands: Generic mupirocin API

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.